世界のシクロベンザプリン医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cyclobenzaprine Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5687
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、シクロベンザプリン医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、カプセル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・シクロベンザプリン医薬品の市場動向
・企業の競争状況、市場シェア
・シクロベンザプリン医薬品の種類別市場規模と予測2016-2027（錠剤、カプセル）
・シクロベンザプリン医薬品の用途別市場規模と予測2016-2027（病院、ドラッグストア）
・シクロベンザプリン医薬品の北米市場規模2016-2027（アメリカ、カナダ）
・シクロベンザプリン医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・シクロベンザプリン医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・シクロベンザプリン医薬品の中南米市場規模2016-2027（メキシコ、ブラジル）
・シクロベンザプリン医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Teva、Mylan、Trupharma、Cipla、Jubilant Cadista、KVK TECH、Aurobindo Pharma、Sun Pharmaceuticals、Apotex）
・結論

Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous system to allow the muscles to relax.

Market Analysis and Insights: Global Cyclobenzaprine Drug Market
The global Cyclobenzaprine Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cyclobenzaprine Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cyclobenzaprine Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cyclobenzaprine Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cyclobenzaprine Drug market.

Global Cyclobenzaprine Drug Scope and Market Size
Cyclobenzaprine Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cyclobenzaprine Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablet
Capsule

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva
Mylan
Trupharma
Cipla
Jubilant Cadista
KVK TECH
Aurobindo Pharma
Sun Pharmaceuticals
Apotex

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cyclobenzaprine Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablet
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Cyclobenzaprine Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cyclobenzaprine Drug Market Perspective (2016-2027)
2.2 Cyclobenzaprine Drug Growth Trends by Regions
2.2.1 Cyclobenzaprine Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cyclobenzaprine Drug Historic Market Share by Regions (2016-2021)
2.2.3 Cyclobenzaprine Drug Forecasted Market Size by Regions (2022-2027)
2.3 Cyclobenzaprine Drug Industry Dynamic
2.3.1 Cyclobenzaprine Drug Market Trends
2.3.2 Cyclobenzaprine Drug Market Drivers
2.3.3 Cyclobenzaprine Drug Market Challenges
2.3.4 Cyclobenzaprine Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cyclobenzaprine Drug Players by Revenue
3.1.1 Global Top Cyclobenzaprine Drug Players by Revenue (2016-2021)
3.1.2 Global Cyclobenzaprine Drug Revenue Market Share by Players (2016-2021)
3.2 Global Cyclobenzaprine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cyclobenzaprine Drug Revenue
3.4 Global Cyclobenzaprine Drug Market Concentration Ratio
3.4.1 Global Cyclobenzaprine Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cyclobenzaprine Drug Revenue in 2020
3.5 Cyclobenzaprine Drug Key Players Head office and Area Served
3.6 Key Players Cyclobenzaprine Drug Product Solution and Service
3.7 Date of Enter into Cyclobenzaprine Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cyclobenzaprine Drug Breakdown Data by Type
4.1 Global Cyclobenzaprine Drug Historic Market Size by Type (2016-2021)
4.2 Global Cyclobenzaprine Drug Forecasted Market Size by Type (2022-2027)

5 Cyclobenzaprine Drug Breakdown Data by Application
5.1 Global Cyclobenzaprine Drug Historic Market Size by Application (2016-2021)
5.2 Global Cyclobenzaprine Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cyclobenzaprine Drug Market Size (2016-2027)
6.2 North America Cyclobenzaprine Drug Market Size by Type
6.2.1 North America Cyclobenzaprine Drug Market Size by Type (2016-2021)
6.2.2 North America Cyclobenzaprine Drug Market Size by Type (2022-2027)
6.2.3 North America Cyclobenzaprine Drug Market Size by Type (2016-2027)
6.3 North America Cyclobenzaprine Drug Market Size by Application
6.3.1 North America Cyclobenzaprine Drug Market Size by Application (2016-2021)
6.3.2 North America Cyclobenzaprine Drug Market Size by Application (2022-2027)
6.3.3 North America Cyclobenzaprine Drug Market Size by Application (2016-2027)
6.4 North America Cyclobenzaprine Drug Market Size by Country
6.4.1 North America Cyclobenzaprine Drug Market Size by Country (2016-2021)
6.4.2 North America Cyclobenzaprine Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cyclobenzaprine Drug Market Size (2016-2027)
7.2 Europe Cyclobenzaprine Drug Market Size by Type
7.2.1 Europe Cyclobenzaprine Drug Market Size by Type (2016-2021)
7.2.2 Europe Cyclobenzaprine Drug Market Size by Type (2022-2027)
7.2.3 Europe Cyclobenzaprine Drug Market Size by Type (2016-2027)
7.3 Europe Cyclobenzaprine Drug Market Size by Application
7.3.1 Europe Cyclobenzaprine Drug Market Size by Application (2016-2021)
7.3.2 Europe Cyclobenzaprine Drug Market Size by Application (2022-2027)
7.3.3 Europe Cyclobenzaprine Drug Market Size by Application (2016-2027)
7.4 Europe Cyclobenzaprine Drug Market Size by Country
7.4.1 Europe Cyclobenzaprine Drug Market Size by Country (2016-2021)
7.4.2 Europe Cyclobenzaprine Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cyclobenzaprine Drug Market Size (2016-2027)
8.2 Asia-Pacific Cyclobenzaprine Drug Market Size by Type
8.2.1 Asia-Pacific Cyclobenzaprine Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cyclobenzaprine Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cyclobenzaprine Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Cyclobenzaprine Drug Market Size by Application
8.3.1 Asia-Pacific Cyclobenzaprine Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cyclobenzaprine Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cyclobenzaprine Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Cyclobenzaprine Drug Market Size by Region
8.4.1 Asia-Pacific Cyclobenzaprine Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cyclobenzaprine Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cyclobenzaprine Drug Market Size (2016-2027)
9.2 Latin America Cyclobenzaprine Drug Market Size by Type
9.2.1 Latin America Cyclobenzaprine Drug Market Size by Type (2016-2021)
9.2.2 Latin America Cyclobenzaprine Drug Market Size by Type (2022-2027)
9.2.3 Latin America Cyclobenzaprine Drug Market Size by Type (2016-2027)
9.3 Latin America Cyclobenzaprine Drug Market Size by Application
9.3.1 Latin America Cyclobenzaprine Drug Market Size by Application (2016-2021)
9.3.2 Latin America Cyclobenzaprine Drug Market Size by Application (2022-2027)
9.3.3 Latin America Cyclobenzaprine Drug Market Size by Application (2016-2027)
9.4 Latin America Cyclobenzaprine Drug Market Size by Country
9.4.1 Latin America Cyclobenzaprine Drug Market Size by Country (2016-2021)
9.4.2 Latin America Cyclobenzaprine Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cyclobenzaprine Drug Market Size (2016-2027)
10.2 Middle East & Africa Cyclobenzaprine Drug Market Size by Type
10.2.1 Middle East & Africa Cyclobenzaprine Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cyclobenzaprine Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cyclobenzaprine Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Cyclobenzaprine Drug Market Size by Application
10.3.1 Middle East & Africa Cyclobenzaprine Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cyclobenzaprine Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cyclobenzaprine Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Cyclobenzaprine Drug Market Size by Country
10.4.1 Middle East & Africa Cyclobenzaprine Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cyclobenzaprine Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Cyclobenzaprine Drug Introduction
11.1.4 Teva Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Cyclobenzaprine Drug Introduction
11.2.4 Mylan Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.2.5 Mylan Recent Development
11.3 Trupharma
11.3.1 Trupharma Company Details
11.3.2 Trupharma Business Overview
11.3.3 Trupharma Cyclobenzaprine Drug Introduction
11.3.4 Trupharma Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.3.5 Trupharma Recent Development
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Cipla Business Overview
11.4.3 Cipla Cyclobenzaprine Drug Introduction
11.4.4 Cipla Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.4.5 Cipla Recent Development
11.5 Jubilant Cadista
11.5.1 Jubilant Cadista Company Details
11.5.2 Jubilant Cadista Business Overview
11.5.3 Jubilant Cadista Cyclobenzaprine Drug Introduction
11.5.4 Jubilant Cadista Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.5.5 Jubilant Cadista Recent Development
11.6 KVK TECH
11.6.1 KVK TECH Company Details
11.6.2 KVK TECH Business Overview
11.6.3 KVK TECH Cyclobenzaprine Drug Introduction
11.6.4 KVK TECH Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.6.5 KVK TECH Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Cyclobenzaprine Drug Introduction
11.7.4 Aurobindo Pharma Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.7.5 Aurobindo Pharma Recent Development
11.8 Sun Pharmaceuticals
11.8.1 Sun Pharmaceuticals Company Details
11.8.2 Sun Pharmaceuticals Business Overview
11.8.3 Sun Pharmaceuticals Cyclobenzaprine Drug Introduction
11.8.4 Sun Pharmaceuticals Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.8.5 Sun Pharmaceuticals Recent Development
11.9 Apotex
11.9.1 Apotex Company Details
11.9.2 Apotex Business Overview
11.9.3 Apotex Cyclobenzaprine Drug Introduction
11.9.4 Apotex Revenue in Cyclobenzaprine Drug Business (2016-2021)
11.9.5 Apotex Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cyclobenzaprine Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablet
Table 3. Key Players of Capsule
Table 4. Global Cyclobenzaprine Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cyclobenzaprine Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cyclobenzaprine Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cyclobenzaprine Drug Market Share by Regions (2016-2021)
Table 8. Global Cyclobenzaprine Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cyclobenzaprine Drug Market Share by Regions (2022-2027)
Table 10. Cyclobenzaprine Drug Market Trends
Table 11. Cyclobenzaprine Drug Market Drivers
Table 12. Cyclobenzaprine Drug Market Challenges
Table 13. Cyclobenzaprine Drug Market Restraints
Table 14. Global Cyclobenzaprine Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cyclobenzaprine Drug Market Share by Players (2016-2021)
Table 16. Global Top Cyclobenzaprine Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclobenzaprine Drug as of 2020)
Table 17. Ranking of Global Top Cyclobenzaprine Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cyclobenzaprine Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cyclobenzaprine Drug Product Solution and Service
Table 21. Date of Enter into Cyclobenzaprine Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cyclobenzaprine Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cyclobenzaprine Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Cyclobenzaprine Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cyclobenzaprine Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cyclobenzaprine Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cyclobenzaprine Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Cyclobenzaprine Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cyclobenzaprine Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cyclobenzaprine Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cyclobenzaprine Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cyclobenzaprine Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cyclobenzaprine Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cyclobenzaprine Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cyclobenzaprine Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cyclobenzaprine Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cyclobenzaprine Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cyclobenzaprine Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cyclobenzaprine Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cyclobenzaprine Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cyclobenzaprine Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cyclobenzaprine Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cyclobenzaprine Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cyclobenzaprine Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cyclobenzaprine Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cyclobenzaprine Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cyclobenzaprine Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cyclobenzaprine Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cyclobenzaprine Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cyclobenzaprine Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cyclobenzaprine Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cyclobenzaprine Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cyclobenzaprine Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cyclobenzaprine Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cyclobenzaprine Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cyclobenzaprine Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cyclobenzaprine Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cyclobenzaprine Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cyclobenzaprine Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Teva Company Details
Table 62. Teva Business Overview
Table 63. Teva Cyclobenzaprine Drug Product
Table 64. Teva Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 65. Teva Recent Development
Table 66. Mylan Company Details
Table 67. Mylan Business Overview
Table 68. Mylan Cyclobenzaprine Drug Product
Table 69. Mylan Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 70. Mylan Recent Development
Table 71. Trupharma Company Details
Table 72. Trupharma Business Overview
Table 73. Trupharma Cyclobenzaprine Drug Product
Table 74. Trupharma Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 75. Trupharma Recent Development
Table 76. Cipla Company Details
Table 77. Cipla Business Overview
Table 78. Cipla Cyclobenzaprine Drug Product
Table 79. Cipla Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 80. Cipla Recent Development
Table 81. Jubilant Cadista Company Details
Table 82. Jubilant Cadista Business Overview
Table 83. Jubilant Cadista Cyclobenzaprine Drug Product
Table 84. Jubilant Cadista Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 85. Jubilant Cadista Recent Development
Table 86. KVK TECH Company Details
Table 87. KVK TECH Business Overview
Table 88. KVK TECH Cyclobenzaprine Drug Product
Table 89. KVK TECH Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 90. KVK TECH Recent Development
Table 91. Aurobindo Pharma Company Details
Table 92. Aurobindo Pharma Business Overview
Table 93. Aurobindo Pharma Cyclobenzaprine Drug Product
Table 94. Aurobindo Pharma Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 95. Aurobindo Pharma Recent Development
Table 96. Sun Pharmaceuticals Company Details
Table 97. Sun Pharmaceuticals Business Overview
Table 98. Sun Pharmaceuticals Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 99. Sun Pharmaceuticals Recent Development
Table 100. Apotex Company Details
Table 101. Apotex Business Overview
Table 102. Apotex Cyclobenzaprine Drug Product
Table 103. Apotex Revenue in Cyclobenzaprine Drug Business (2016-2021) & (US$ Million)
Table 104. Apotex Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cyclobenzaprine Drug Market Share by Type: 2020 VS 2027
Figure 2. Tablet Features
Figure 3. Capsule Features
Figure 4. Global Cyclobenzaprine Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Cyclobenzaprine Drug Report Years Considered
Figure 8. Global Cyclobenzaprine Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Cyclobenzaprine Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Cyclobenzaprine Drug Market Share by Regions: 2020 VS 2027
Figure 11. Global Cyclobenzaprine Drug Market Share by Regions (2022-2027)
Figure 12. Global Cyclobenzaprine Drug Market Share by Players in 2020
Figure 13. Global Top Cyclobenzaprine Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclobenzaprine Drug as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Cyclobenzaprine Drug Revenue in 2020
Figure 15. Global Cyclobenzaprine Drug Revenue Market Share by Type (2016-2021)
Figure 16. Global Cyclobenzaprine Drug Revenue Market Share by Type (2022-2027)
Figure 17. North America Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Cyclobenzaprine Drug Market Share by Type (2016-2027)
Figure 19. North America Cyclobenzaprine Drug Market Share by Application (2016-2027)
Figure 20. North America Cyclobenzaprine Drug Market Share by Country (2016-2027)
Figure 21. United States Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cyclobenzaprine Drug Market Share by Type (2016-2027)
Figure 25. Europe Cyclobenzaprine Drug Market Share by Application (2016-2027)
Figure 26. Europe Cyclobenzaprine Drug Market Share by Country (2016-2027)
Figure 27. Germany Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cyclobenzaprine Drug Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Cyclobenzaprine Drug Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Cyclobenzaprine Drug Market Share by Region (2016-2027)
Figure 37. China Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cyclobenzaprine Drug Market Share by Type (2016-2027)
Figure 45. Latin America Cyclobenzaprine Drug Market Share by Application (2016-2027)
Figure 46. Latin America Cyclobenzaprine Drug Market Share by Country (2016-2027)
Figure 47. Mexico Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cyclobenzaprine Drug Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Cyclobenzaprine Drug Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Cyclobenzaprine Drug Market Share by Country (2016-2027)
Figure 53. Turkey Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Cyclobenzaprine Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Teva Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 57. Mylan Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 58. Trupharma Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 59. Cipla Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 60. Jubilant Cadista Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 61. KVK TECH Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 62. Aurobindo Pharma Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 63. Sun Pharmaceuticals Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 64. Apotex Revenue Growth Rate in Cyclobenzaprine Drug Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年）

Global Hypothyroidism Drug Market Size, Status and Forecast 2021-2027
QFJ1-4342 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、甲状腺機能低下症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）、用途別市場規模（病院、診療所、その他）、主要地域...

世界の抗コリン薬市場規模・現状・予測（2021年-2027年）

Global Anticholinergic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5583 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗コリン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口、局所）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年）

Global Acute Hepatic Porphyria Drug Market Size, Status and Forecast 2021-2027
QFJ1-5564 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、急性肝性ポルフィリン症用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（350 Mg、313 Mg）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメ...

世界のデシタビン薬市場規模・現状・予測（2021年-2027年）

Global Decitabine Drug Market Size, Status and Forecast 2021-2027
QFJ1-5691 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、デシタビン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダコゲン、ジェネリック）、用途別市場規模（病院、ドラックストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Meniere Disease Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4490 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、メニエール病治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（めまい、耳分泌物、その他）、用途別市場規模（病院・クリニック、専門センター）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年） Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Market Analysis and Insights: Global Ambrisentan Drug Market The global Ambrisentan Drug market size is projected to reach …
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypothyroidism Drug Market The global Hypothyroidism Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
世界のデシタビン薬市場規模・現状・予測（2021年-2027年） Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). Market Analysis and Insights:…
世界の抗コリン薬市場規模・現状・予測（2021年-2027年） Anticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, digestion, and several others. The drug i…